Navigation Links
GenVec Reports Fourth Quarter And 2012 Year-End Financial Results
Date:3/22/2013

2013 GuidanceGenVec's Senior Vice President and Chief Financial Officer, Douglas J. Swirsky , commented, "For 2013, we anticipate our cash burn will be between $8.0 million and $9.0 million."

Conference Call InformationGenVec will hold a conference call today at 10:00 a.m. EDT to discuss the Company's financial results and 2013 business outlook.  To listen to the live conference call, please dial 877-558-0567 (U.S. or Canada) or 706-643-4980 (international) and use the following Conference ID: 17801867.  An audio replay of the conference call will be available starting at 1:00 p.m. EDT on March 22, 2013 through March 29, 2013.  To listen to the audio replay, dial 855-859-2056 or 404-537-3406 (international) and use access code 17801867.

A live webcast of the conference call will be available on the Company's website and will be archived for 30 days.  To access the webcast or the replay, go to www.genvec.com, and click on "Investors and Media".

About GenVecGenVec is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. A key component of our strategy is to develop and commercialize our product candidates through collaborations. GenVec is working with leading companies and organizations such as Novartis, Merial, and the U.S. Government to support a portfolio of product programs that address the prevention and treatment of a number of significant human and animal health concerns. GenVec's development programs address therapeutic areas such as hearing loss and balance disorders; as well as vaccines against infectious diseases including respiratory syncytial virus (RSV), herpes simplex virus (HSV), dengue fever, malaria, and human immunodeficiency virus (HIV). In the area of animal health we are developing vaccines against foot-and-mouth disease (FMD). Addit
'/>"/>

SOURCE GenVec, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. GenVec To Release First Quarter 2012 Financial Results And Conduct A Conference Call On May 10, 2012
2. GenVec Appoints Cynthia Collins as President and CEO
3. GenVec Reports Inducement Award
4. GenVec Announces Conditional Approval of FMD Vaccine for Cattle
5. GenVec to Release Second Quarter 2012 Financial Results and Conduct a Conference Call on August 9, 2012
6. GenVec Reports Second Quarter 2012 Financial Results
7. GenVec Reports Third Quarter 2012 Financial Results
8. GenVec to Present at 25th Annual ROTH Conference
9. GenVec To Release Fourth Quarter And Year-end 2012 Financial Results And Conduct A Conference Call On March 22, 2013
10. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
11. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014 MarketResearchreports.biz presents ... Insulin Market (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, Premixed, And ... Growth, Trends and Forecast (Value and Volume), 2013 - ... Diabetes, growing at an exponential rate worldwide, has ... as a major cause of death of people between ...
(Date:7/30/2014)... 2014  There is still time to share ... 10th Annual Institute for Supply Management ® ... Supply Management is open for submissions.  The annual ... importance of supply management by recognizing supply management ... management practices.  Entries are due August 22, 2014. ...
(Date:7/30/2014)... July 30, 2014  Hologic, Inc. (NASDAQ: ... fiscal quarter ended June 28, 2014. Third ... increased 1.0% to $632.6 million, reflecting operational growth of ... to the same period in the prior year. ... segments. , Breast Health revenues grew 3.5%. , ...
Breaking Medicine Technology:The Global and China Insulin Market is Expected to Grow at a CAGR of 6.1% From 2013 to 2019 to Reach USD 32.24 Billion in 2019 2The Global and China Insulin Market is Expected to Grow at a CAGR of 6.1% From 2013 to 2019 to Reach USD 32.24 Billion in 2019 3The Global and China Insulin Market is Expected to Grow at a CAGR of 6.1% From 2013 to 2019 to Reach USD 32.24 Billion in 2019 4The Global and China Insulin Market is Expected to Grow at a CAGR of 6.1% From 2013 to 2019 to Reach USD 32.24 Billion in 2019 5The Global and China Insulin Market is Expected to Grow at a CAGR of 6.1% From 2013 to 2019 to Reach USD 32.24 Billion in 2019 6The Global and China Insulin Market is Expected to Grow at a CAGR of 6.1% From 2013 to 2019 to Reach USD 32.24 Billion in 2019 7The Global and China Insulin Market is Expected to Grow at a CAGR of 6.1% From 2013 to 2019 to Reach USD 32.24 Billion in 2019 8Institute for Supply Management, Michigan State University to recognize companies with excellent supply management practices 2Hologic Announces Third Quarter Fiscal 2014 Operating Results 2Hologic Announces Third Quarter Fiscal 2014 Operating Results 3Hologic Announces Third Quarter Fiscal 2014 Operating Results 4Hologic Announces Third Quarter Fiscal 2014 Operating Results 5Hologic Announces Third Quarter Fiscal 2014 Operating Results 6Hologic Announces Third Quarter Fiscal 2014 Operating Results 7Hologic Announces Third Quarter Fiscal 2014 Operating Results 8Hologic Announces Third Quarter Fiscal 2014 Operating Results 9Hologic Announces Third Quarter Fiscal 2014 Operating Results 10Hologic Announces Third Quarter Fiscal 2014 Operating Results 11Hologic Announces Third Quarter Fiscal 2014 Operating Results 12Hologic Announces Third Quarter Fiscal 2014 Operating Results 13Hologic Announces Third Quarter Fiscal 2014 Operating Results 14Hologic Announces Third Quarter Fiscal 2014 Operating Results 15Hologic Announces Third Quarter Fiscal 2014 Operating Results 16Hologic Announces Third Quarter Fiscal 2014 Operating Results 17
... 30, 2011 Ampio Pharmaceuticals, Inc. (NASDAQ: ... discovers and develops new uses for previously approved drugs ... manuscript reporting the results of its phase III clinical ... dysfunction, premature ejaculation (PE), was accepted for publication in ...
... Accuray Incorporated (Nasdaq: ARAY ), ... in use of the CyberKnife® Robotic Radiosurgery System ... company experienced a 24 percent increase in worldwide prostate treatments ... 2011. Continued momentum in the adoption of CyberKnife prostate SBRT ...
Cached Medicine Technology:Zertane™ Clinical Results Published in the Journal European Urology 2Zertane™ Clinical Results Published in the Journal European Urology 3Accuray Drives Growth in Radiosurgery for Early-Stage Prostate Cancer 2Accuray Drives Growth in Radiosurgery for Early-Stage Prostate Cancer 3Accuray Drives Growth in Radiosurgery for Early-Stage Prostate Cancer 4Accuray Drives Growth in Radiosurgery for Early-Stage Prostate Cancer 5
(Date:7/31/2014)... July 31, 2014 ReputationChief.Com, a ... new online reputation management service named ‘Remove Pissed ... as organizations get rid of Pissed Consumer Complaints. ... of extensive research. ReputationChief.Com management assigned the responsibility ... those who are struggling in their social or ...
(Date:7/31/2014)... -- A new study by researchers at Sanford-Burnham Medical ... caerulein can convert existing cells in the pancreas into ... The study, published online July 31 in Cell ... treating the estimated 3 million people in the U.S., ... diabetes. , "We have found a promising technique for ...
(Date:7/31/2014)... La Mirada, CA (PRWEB) July 31, 2014 ... California’s leading healthcare providers, strives in maintaining the ... and employers. That is why Healthpointe is offering ... facility to surrounding employers, employees and patients. They ... from insurance carriers. , Healthpointe’s Occupational Medicine services ...
(Date:7/31/2014)... 31, 2014 Dallas Fit Body Boot ... Texas to 3821 Ross Avenue, also in Dallas, in an ... potential members to burn fat and get in great shape ... because he believes that the new space will help his ... results they want as well as accommodate new members interested ...
(Date:7/31/2014)... With a busy lifestyle, it is hard to relax. World ... but to ensure their mental health is equally in check. ... right is key to your body’s health. However, I want everyone ... healthy lifestyle,” expressed Chef Ravi, owner of World Gardens Cafe. Check ... , ", 1. Stop eating lunch at your desk or taking ...
Breaking Medicine News(10 mins):Health News:ReputationChief.Com Announces a New Online Reputation Management Service 2Health News:A new way to generate insulin-producing cells in Type 1 diabetes 2Health News:Occupational Medicine Services Available at Healthpointe’s Perris Facility 2Health News:Dallas Fit Body Boot Camp Moves to New Location, Announces Grand Opening Set for Saturday August 9th 2Health News:World Garden’s Cafe Launches ‘16 Simple Ways to Feel Connected to the World’ 2Health News:World Garden’s Cafe Launches ‘16 Simple Ways to Feel Connected to the World’ 3Health News:World Garden’s Cafe Launches ‘16 Simple Ways to Feel Connected to the World’ 4
... including physical activity and structured weight loss programs, can result ... adults, according to two reports that were posted online today ... were made available early online to coincide with the presentation ... the Obesity Society. The articles will appear in the ...
... FRIDAY, Oct. 8 (HealthDay News) -- A new diagnostic tool ... the lining of the cheek show some promise in preliminary ... screening approach functions as a kind of optical sweep of ... located far from the site of an actual tumor undergo ...
... Oct. 12, 2010 Researchers at UT Southwestern ... the small protein that forms plaques in the brain ... Alzheimer,s disease. Compared with similar so-called DNA ... animal study, the new experimental vaccine stimulated more than ...
... , FRIDAY, Oct. 8 (HealthDay News) -- Weight-loss surgery ... obese teenagers, particularly those who are beginning to show ... obesity has become a serious public health concern in ... one in every four teenagers is obese, according to ...
... and Infectious Diseases, part of the National Institutes of ... at the Virginia Bioinformatics Institute (VBI) and collaborators to ... by pathogens of the gut. The funding will be ... immune responses to gut pathogens. "The Center for ...
... are the most widely used medical tests in the world. ... continue to discover new uses for it, ranging from more ... complex, a sonographer,s skill level is even more important. ... one of the keys to becoming a successful sonographer: spatial ...
Cached Medicine News:Health News:Clinical trials demonstrate effective weight loss strategies for obese and overweight adults 2Health News:Clinical trials demonstrate effective weight loss strategies for obese and overweight adults 3Health News:New Tool Shows Promise for Early Lung Cancer Screening 2Health News:New Tool Shows Promise for Early Lung Cancer Screening 3Health News:UT Southwestern researchers create experimental vaccine against Alzheimer's 2Health News:Weight-Loss Surgery for Teens May Be Gaining Advocates 2Health News:Weight-Loss Surgery for Teens May Be Gaining Advocates 3Health News:Virginia Bioinformatics Institute to model immune responses to gut pathogens 2Health News:Virginia Bioinformatics Institute to model immune responses to gut pathogens 3Health News:Improving sonography requires improving sonography school admissions 2
The AGC Revision Knee, extends the AGC Family to include implants for severe primary knees or revision. Provides rotational freedom of +/- 2 and varus/valgus freedom of +/- 1.5....
The Performance Knee System is a wide and easy to use system that offers enough options to cover any indication for primary and revision knee surgery, and all this with extensive intraoperative flexi...
The NexGen CR femoral component is intended for patients who, in the physician's judgement, have good bone stock and whose ligaments provide adequate mediolateral, anteroposterior, and varus/valgus s...
Cruciate retaining, posterior stabilized and constrained components....
Medicine Products: